Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3-1-10, Takanodai, Nerima-City, Tokyo, 177-8521, Japan.
Department of Sport Management, Faculty of Business Informatics, Jobu University, 634-1, Toya-Chou, Isesaki-City, Gunma, 372-8588, Japan.
J Transl Med. 2023 Aug 31;21(1):584. doi: 10.1186/s12967-023-04416-9.
Disasters and accidents have occurred with increasing frequency in recent years. Primary disasters have the potential to result in mass casualty events involving crush syndrome (CS) and other serious injuries. Prehospital providers and emergency clinicians stand on the front lines of these patients' evaluation and treatment. However, the bulk of our current knowledge, derived from historical data, has remained unchanged for over ten years. In addition, no evidence-based treatment has been established to date.
This narrative review aims to provide a focused overview of, and update on, CS for both prehospital providers and emergency clinicians.
CS is a severe systemic manifestation of trauma and ischemia involving soft tissue, principally skeletal muscle, due to prolonged crushing of tissues. Among earthquake survivors, the reported incidence of CS is 2-15%, and mortality is reported to be up to 48%. Patients with CS can develop cardiac failure, kidney dysfunction, shock, systemic inflammation, and sepsis. In addition, late presentations include life-threatening systemic effects such as hypovolemic shock, hyperkalemia, metabolic acidosis, and disseminated intravascular coagulation. Immediately beginning treatment is the single most important factor in reducing the mortality of disaster-situation CS. In order to reduce complications from CS, early, aggressive resuscitation is recommended in prehospital settings, ideally even before extrication. However, in large-scale natural disasters, it is difficult to diagnose CS, and to reach and start treatments such as continuous administration of massive amounts of fluid, diuresis, and hemodialysis, on time. This may lead to delayed diagnosis of, and high on-site mortality from, CS. To overcome these challenges, new diagnostic and therapeutic modalities in the CS animal model have recently been advanced.
Patient outcomes can be optimized by ensuring that prehospital providers and emergency clinicians maintain a comprehensive understanding of CS. The field is poised to undergo significant advances in coming years, given recent developments in what is considered possible both technologically and surgically; this only serves to further emphasize the importance of the field, and the need for ongoing research.
近年来,灾害和事故的发生频率不断增加。原发性灾害有可能导致涉及挤压综合征(CS)和其他严重损伤的大规模伤亡事件。院前提供者和急诊临床医生站在这些患者评估和治疗的第一线。然而,我们目前的大部分知识,源自历史数据,十年来一直没有改变。此外,迄今为止尚未建立循证治疗方法。
本叙述性综述旨在为院前提供者和急诊临床医生提供有关 CS 的重点概述和最新信息。
CS 是一种严重的全身性创伤和缺血性疾病,主要累及软组织,主要是骨骼肌,由于组织长时间受压。在地震幸存者中,CS 的报告发病率为 2-15%,死亡率报告高达 48%。CS 患者可发生心力衰竭、肾功能障碍、休克、全身炎症和败血症。此外,晚期表现包括威胁生命的全身效应,如低血容量性休克、高钾血症、代谢性酸中毒和弥漫性血管内凝血。立即开始治疗是降低灾害性 CS 死亡率的唯一最重要因素。为了减少 CS 的并发症,建议在院前环境中尽早、积极地复苏,理想情况下甚至在救援之前。然而,在大规模自然灾害中,CS 很难诊断,并且很难及时进行连续给予大量液体、利尿和血液透析等治疗,这可能导致 CS 的延迟诊断和现场高死亡率。为了克服这些挑战,最近在 CS 动物模型中提出了新的诊断和治疗方法。
通过确保院前提供者和急诊临床医生全面了解 CS,可以优化患者的结局。鉴于近年来在技术和手术方面认为可能的方面取得了重大进展,该领域有望在未来几年取得重大进展;这进一步强调了该领域的重要性以及持续研究的必要性。